-
UPDATE: RBC Capital Upgrades AVEO Pharmaceuticals (AVEO) to Sector Perform
-
RBC Capital Downgrades AVEO Pharmaceuticals (AVEO) to Underperform
-
Notable 52-Week Highs and Lows of the Day 12/13: (ADBE) (AER) (NLSN) High; (LULU) (AVEO) (DGX) Low
-
RBC Capital Downgrades AVEO Pharmaceuticals (AVEO) to Sector Perform
-
AVEO Pharmaceuticals (AVEO) Prices Offering at $7.50/Sh
-
AVEO Pharmaceuticals (AVEO) Plans Stock Offering
-
RBC Capital Starts AVEO Pharma (AVEO) at Outperform, Sets $24 Price Target
-
AVEO Pharma (AVEO) Executes $61M of PIPE Financing

